Impact Factor
3.46
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.41
1,408 total citations
h5-index
40
h5 depth signal
Cited share
67.0%
427 of 637
Total citations
1,408
Citation footprint
Metric signal
2.20
External metric anchor
Self-citation
7.5%
106 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,989
United Kingdom
456
South Africa
341
France
283
Canada
250
Citing Fields of Research
HIV
3,145
Hepatitis
222
Immunology
206
Oncology
141
Sexually Transmitted Diseases
109
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
15,696
Articles tracked across the journal lifetime
Indexed publication set
637
427 cited publications
Last 12 months
272
22.7 publications/month
Open access share
28.3%
77 OA publications in the last year
Leading citing country
United States
1,989 citing publications
Leading citing field
HIV
3,145 citing publications
Latest tracked publication
8 October 2026
10 recent records available
Coverage & Indexing History
v1n1,May 1987-
v1n1,May 1987-
Active Coverage
Research Focus & Classification
Indexed Subjects
HIV
Broad Categories
Acquired Immunodeficiency Syndrome
HIV
MeSH Descriptors
Acquired Immunodeficiency Syndrome
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/qad.0000000000004633
Open DOI
Higher plasma kynurenine-tryptophan ratio predicts incident hepatic fibrosis in women with HIV
Objective: Chronic immune activation and microbial translocation may contribute to hepatic fibrosis in people with HIV. We evaluated whether plasma kynurenine-to-tryptophan (KT) ratio and other biomarkers of microbial translocation predi...
02
DOI 10.1097/qad.0000000000004631
Open DOI
Traditional healers in HIV differentiated service delivery
Background: Despite widespread adoption of differentiated service delivery (DSD) models for HIV care in Uganda, nearly one-third of people with HIV remain virally unsuppressed, and 30–60% of those initiating antiretroviral therapy (ART) ...
03
DOI 10.1097/qad.0000000000004638
Open DOI
Consent understanding and willingness to participate in research among adolescents and young adults living with HIV
Background: There are limited data regarding informed consent understanding and research decision-making among youth in sub-Saharan Africa. Methods: Adolescents and young adults living with HIV (AYLHIV) aged 10–24 years and adult caregiv...
04
DOI 10.1097/qad.0000000000004634
Open DOI
Plasma–genital HIV-1 RNA discordance in women: early observations and biological interpretation in the U=U era
Even in light of reports of plasma–genital HIV-1 RNA discordance, the clinical and public-health message of undetectable = untransmittable (U = U) remains robust.
05
DOI 10.1097/qad.0000000000004632
Open DOI
Female sex is associated with continuous decline in intact HIV-1 proviruses during long-term antiretroviral therapy
Background: Understanding the factors associated with long-term intact HIV-1 proviral dynamics during suppressive ART is critical for developing HIV-1 cure strategies. In this study, we sought to evaluate the association between sex assi...
06
DOI 10.1097/qad.0000000000004637
Open DOI
Exercise testing and single-photon emission computed tomography myocardial perfusion imaging to detect silent coronary heart disease in people with HIV
Objective: To evaluate the relevance of single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) combined with exercise testing, performed in asymptomatic people with HIV receiving effective antiretroviral th...
07
DOI 10.1097/qad.0000000000004635
Open DOI
Adherence to European AIDS clinical society hepatitis B management guidelines in people with HIV: real-world evidence from Spain and Germany
Objective: To evaluate adherence to hepatitis B virus (HBV) management recommendations among people with HIV (PWH) and chronic HBV infection. Design: A multicenter cross-sectional study. Methods: We conducted a cross-sectional study in 4...
08
DOI 10.1097/qad.0000000000004639
Open DOI
Tryptophan metabolomic profiling in persons with and without HIV
Background: Full tryptophan (T) profiling allows determination of T-metabolites from the serotonin, kynurenine (K) and gut-integrity/indole pathways. We assessed T-metabolites, depressive symptoms, cognitive function and sleep measures i...
09
DOI 10.1097/qad.0000000000004582
Open DOI
An inclusive approach for developing global clinical trial recommendations
Was not provided for this article.
10
DOI 10.1097/qad.0000000000004601
Open DOI
Cognitive trajectories in HIV: looking beyond the virus to preserve brain health
Was not provided for this article.
Bibliographical & Catalog Notes
Title from cover.
Imprint varies.
Vols. for 1990?- accompanied by supplements, including AIDS ... a year in review.
Also issued online.
Vol. 1, no. 1 (MAY 1987)19900511 Notice not published Printed on acid-free paper